We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee unanimously voted to expand the drug’s label last month after previously turning it down. Read More
Michigan’s attorney general has filed suit against four major drug distributors for their alleged role in the opioid crisis — invoking for the first time a law that allows the state to pursue drug dealers for civil damages. Read More
President Trump signed a fiscal 2020 federal budget package into law Friday that increases funding for the FDA for the third time in three years. Read More
The National Academies of Sciences, Engineering and Medicine (NASEM) offered recommendations for creating opioid prescribing guidelines in a report released Thursday. Read More